These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11362690)

  • 1. The next wave of protease inhibitors.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):4. PubMed ID: 11362690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitor trials moving to next phase.
    AIDS Alert; 1995 Aug; 10(8):100-1. PubMed ID: 11362675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agouron protease inhibitor AG1343: activity reported.
    James JS
    AIDS Treat News; 1995 May; (no 222):6. PubMed ID: 11362464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral resistance to protease inhibitors.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):1, 4-5. PubMed ID: 11362685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agouron protease inhibitor.
    AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More clinical data on protease inhibitors.
    Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):4-7. PubMed ID: 11362917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitors at Retroviruses Conference: Agouron's results.
    James JS
    AIDS Treat News; 1996 Mar; (no 242):5-6. PubMed ID: 11363194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors: resistance, resistance, resistance.
    Gilden D; Falkenberg J; Torres G
    GMHC Treat Issues; 1997 Feb; 11(2):5-10. PubMed ID: 11364108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical potential of a new HIV protease inhibitor.
    Chapman S; Peterkin J; Quart B; Youle M
    J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):24. PubMed ID: 11362604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drug approved to treat HIV.
    Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitor update.
    Colvin R; Haas G
    Common Factor; 1995 Apr; (no 10):15. PubMed ID: 11362340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nelfinavir - major trial results at retroviruses conference.
    AIDS Treat News; 1997 Feb; (No 265):3-4. PubMed ID: 11364240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Other options: clinical trials.
    Treat Rev; 1998; (No 28):13-4. PubMed ID: 11365420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ongoing protease inhibitor trials.
    GMHC Treat Issues; 1995 Jun; 9(6):2. PubMed ID: 11362688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nelfinavir is number 4 -- but should it bat cleanup, or lead off?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):17-21. PubMed ID: 11364427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nelfinavir (Viracept) moves up the ranks.
    Grodeck B
    Posit Aware; 1997; 8(2):16-7. PubMed ID: 11364452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABT-538 increases CD4 counts.
    Posit Aware; 1995; ():4. PubMed ID: 11362207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antiretroviral drugs part I: PIs.
    Murphy RL
    AIDS Clin Care; 1999 May; 11(5):35-7. PubMed ID: 11367101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.